Immuneering Corp’s recently made public that its Director HAUSMAN DIANA acquired Company’s shares for reported $10874.0 on Jul 02 ’25. In the deal valued at $3.62 per share,3,000 shares were bought. As a result of this transaction, HAUSMAN DIANA now holds 3,000 shares worth roughly $12510.0.
Then, HAUSMAN DIANA bought 2,500 shares, generating $8,989 in total proceeds. Upon buying the shares at $3.60, the Director now owns 2,500 shares.
Before that, Neufeld Leah R bought 700 shares. Immuneering Corp shares valued at $2,499 were divested by the CHIEF PEOPLE OFFICER at a price of $3.57 per share. As a result of the transaction, Neufeld Leah R now holds 10,729 shares, worth roughly $44739.93.
Morgan Stanley downgraded its Immuneering Corp [IMRX] rating to an Underweight from a an Equal-weight in a research note published recently. A number of analysts have revised their coverage, including Needham’s analysts, who remained covering the stock and in mid March has reiterated a ‘”a Buy”‘ rating for it. TD Cowen also remained covering IMRX and has decreased its forecast on March 15, 2024 with a “Market perform” recommendation from previously “an Outperform” rating. Jefferies revised its rating on March 15, 2024. It rated IMRX as “a Hold” which previously was an “a Buy”.
Price Performance Review of IMRX
On Monday, Immuneering Corp [NASDAQ:IMRX] saw its stock fall -5.66% to $4.17. Over the last five days, the stock has gained 2.96%. Immuneering Corp shares have risen nearly 211.19% since the year began. Nevertheless, the stocks have risen 89.55% over the past one year. While a 52-week high of $4.60 was reached on 07/09/25, a 52-week low of $1.00 was recorded on 05/12/25.
Levels Of Support And Resistance For IMRX Stock
The 24-hour chart illustrates a support level at 3.90, which if violated will result in even more drops to 3.62. On the upside, there is a resistance level at 4.50. A further resistance level may holdings at 4.82.
How much short interest is there in Immuneering Corp?
A steep rise in short interest was recorded in Immuneering Corp stocks on 2025-06-13, growing by 0.23 million shares to a total of 0.89 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 0.66 million shares. There was a rise of 26.07%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 01, 2023 when Needham began covering the stock and recommended ‘”a Buy”‘ rating along with a $20 price target.
